Multicentre prospective clinical application of the T14 paediatric outcome tool

C Hopkins1, R Almeyda2, H Alreefy1

  • 1Evelina London Children's Hospital,Guy's and St Thomas' NHS Trust,London,UK.

Insights

Children undergoing tonsillectomy or adenotonsillectomy experienced significant improvements in disease-specific quality of life. Even those managed conservatively improved, with many eventually opting for surgery.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Quality of Life Research

Background:

  • Tonsillectomy and adenotonsillectomy are common pediatric surgical procedures.
  • Assessing disease-specific quality of life (QoL) is crucial for evaluating surgical outcomes in children.

Purpose of the Study:

  • To measure changes in disease-specific quality of life in children after tonsillectomy or adenotonsillectomy.
  • To compare QoL outcomes between surgical and conservative management of throat problems in children.

Main Methods:

  • A multicentre prospective cohort study involving 276 children across seven ENT departments in England.
  • Follow-up data collected over 12 months using T14 scores, parental QoL impressions, and school absence days.
  • Groups included tonsillectomy (n=107), adenotonsillectomy (n=128), and watchful waiting (n=41).

Main Results:

  • One-year follow-up data available for 150 patients (52%).
  • Significant improvement in T14 scores observed in all groups (non-surgical, tonsillectomy, adenotonsillectomy) at follow-up.
  • Effect sizes for QoL improvement ranged from 1.3 to 2.1 SD, with no statistically significant between-group differences.

Conclusions:

  • Surgical intervention (tonsillectomy/adenotonsillectomy) significantly enhances disease-specific quality of life in children.
  • Conservative management also leads to QoL improvements, but a substantial proportion (1 in 3) eventually undergo surgery.
  • Findings highlight the benefits of surgery for severe cases and the potential for conservative management in milder cases, with a notable crossover rate.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
378
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762